Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc
New Medimix Asia Commercial Manager Brings Valuable Experience in Chinese Lifesciences Market
Medimix Asia announces the appointment of Jiayin He as Commercial Manager in its Shanghai office. Ms. He brings a comprehensive knowledge of the fields of biotechnology and chemistry, as well as medical research, license applications, and pharmaceutical sales in the Chinese hospital environment. This combined understanding of medical research and Chinese doctors’ behavior promises to offer invaluable insights to life science companies seeking to enter or expand in the Asian markets. - January 12, 2011 - Medimix International
iPharmacy Named the Best iPhone App for Prescription Reference
iPharmacy was featured in a new book, “Best iPhone Apps,” by J D Biersdorfer J.D. as the “Best iPhone App for Prescription Reference.” - January 06, 2011 - SigmaPhone
Affinity Life Sciences Announces Expansion of Their cGMP Manufacturing Facility to Provide Additional Capacity for Biomarker Assay Development and Lyophilization Services
Affinity Life Sciences, Inc. is a New England based contract manufacturing and research organization committed to providing scientific and quality expertise to meet the unique production demands of the biotechnology and pharmaceutical industries worldwide. Affinity's introduction of this space allows for even greater capacity and efficiency for projects ranging from R&D to cGMP compliant production. - December 31, 2010 - Affinity Life Sciences
Biotage Extends Capabilities with Addition of PEG Resins for Solid Phase Peptide Synthesis
Biotage announces the addition of ChemMatrix® resins to its extensive offering of peptide synthesis and purification products. ChemMatrix offers substantial advantages over traditional PS and PEG based resins for solid phase peptide synthesis. - December 08, 2010 - Biotage
CIS Makes Catching Up with Supplier Audits Easier with Free Program Assessment for Pharma Manufacturers
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that it will offer a free supplier management program assessment to pharmaceutical manufacturers in an effort to assist them with their 2010-2011 supplier audits. “As a former Director of... - December 08, 2010 - Compliance Implementation Services
Breakthrough in Telehealth, Introducing the MedPod by Daya Medicals
This week for the first time, Daya Medicals, Inc. will present its game-changing patient-centered medication dispensing and data coordinating “cloud” based hub (newest product), the MedPod, to a select group of industry specialists and health care professionals in Miami. - December 08, 2010 - Daya Medicals
Spotaway™- a Licensed Cream for the Treatment of Acne, Spots & Pimples
Chrysalis Health & Beauty Limited have announced the availability of Spotaway™ a licensed OTC medicine for the treatment of Acne, Spots and Pimples for private labeling in the UK and overseas. - December 02, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Successfully Increasing Capsule Potency Using Roller Compaction
Metrics scientist presents case study during AAPS poster session - November 20, 2010 - Metrics, Inc.
Metrics AAPS Poster Presentation Examines Filler Moisture Absorption
Long-term storage comparative analysis between two common fillers finds mannitol protects better - November 19, 2010 - Metrics, Inc.
Biopharmaceuticals Market to Reach More Than US$ 167 Billion by 2015
Biopharmaceuticals enjoy a higher approval success rate compared to traditional small molecule drugs. They, however, require higher investments and take longer development times. - November 19, 2010 - MarketResearch.com
Metrics Scientist Finds Varnish Molecule Migrates Through Bottle
AAPS poster presentation examines how molecule migrated from label through bottle onto drug - November 18, 2010 - Metrics, Inc.
Metrics Launches New Video Monitoring Service "PharmaVision"
A first for a CDMO, new web-based streaming video offers clients "man in plant" oversight - November 17, 2010 - Metrics, Inc.
Three Metrics Scientists to Present at AAPS Annual Meeting
Research reflects thoughtfulness that company scientists put into solving clients’ problems. - November 13, 2010 - Metrics, Inc.
Drug Delivery Market Forecasted to Grow 10.3% Annually Through 2016
This report provides the key data and analyzes the major challenges and drivers for the Oral Drug Delivery Market. - November 12, 2010 - MarketResearch.com
Foamix Receives US Patent for Oleaginous Foam
Oleaginous Foams – Ideal Vehicles for Lipophilic and Water-Sensitive Drugs, such as Vitamin D, Retinoids and Lipophilic Antibiotics. - November 06, 2010 - Foamix Ltd
US Pharma Companies Face Revenue Declines from Patent Expirations
This report covers the US prescription pharmaceutical market and how it will be affected by US healthcare reform - November 05, 2010 - MarketResearch.com
Compliance Implementation Services’ Collins Speaks at Executive Roundtable on Greater CFO-CIO Collaboration
CIS' Chief Financial Officer and Vice President of Operations Jim Collins recently participated in the 5th annual Robert Half Executive Roundtable discussion at the Carolina Club on the campus of the University of North Carolina to address increased Chief Financial Officer-Chief Information Officer collaboration. - November 05, 2010 - Compliance Implementation Services
Cypin Production Announces Launch of U.S./China BioPharma Conference
“Innovative Strategies and Partnership Models for R&D Success.” - November 05, 2010 - CYPIN PRODUCTION LLC
The Top 10 Eastern European Pharmaceutical Companies: Growth Strategies, Performance and SWOT Analyses Now Available at ReportsandReports
The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends. It also provides the competitive landscape of the industry based on financial and operational (revenue growth over the last five years, exposure to major markets and presence in major therapeutic areas) parameters in the Eastern European region. - November 03, 2010 - marketsandmarkets
Foamix and BioMAS to Develop Novel Therapy for Genital Warts
The New Drug Will Target One of the Most Common Sexually Transmitted Disease, Afflicting More Than 20 Million Americans. - November 03, 2010 - Foamix Ltd
Inspire CEO to Address Healthcare Digital Marketing Conference
Brian Loew, CEO of Inspire, will be a featured speaker at the DTC 2010 Fall Conference, “Marketing to the Digital Consumer – A Healthcare Perspective.” Princeton, NJ-based Inspire creates safe, moderated online communities, organized by medical condition, for patients to share information and to support each other. - October 31, 2010 - Inspire
HighPoint Solutions VP Chris Colapietro on Panel at Next Generation Pharma Sales & Marketing Summit
HighPoint Solutions (HighPoint) announced today that Chris Colapietro, Vice President of Strategy & Marketing, will be a panelist at the Next Generation Pharma Sales & Marketing Summit, November 16-17 in Baltimore, Maryland. - October 29, 2010 - HighPoint Solutions, LLC
Fox of Compliance Implementation Services Re-Elected to PDMA Alliance Board
CIS, a pharmaceutical compliance consulting firm, announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been re-elected to a three-year term on the PDMA Alliance Inc. Board of Directors. - October 29, 2010 - Compliance Implementation Services
Newly Established CYPIN PRODUCTION Addresses Win-Win Situation: Building Bridges Between U.S. BioPharma and China
While major developed markets for biopharmaceuticals and life sciences will grow just 3 percent to 6 percent through 2014, emerging markets are expected to grow between 14 percent and 17 percent. One of these especially vital and growing markets in biopharma is China. - October 27, 2010 - CYPIN PRODUCTION LLC
Platinum Cured Silicone Tubing from AdvantaPure(R) Now Stocked in 49 Sizes from 0.03” to 1” I.D.
AdvantaPure now offers its APST silicone tubing in nearly 50 sizes for use in pharmaceutical, biotech, biomedical, chemical, food, and beverage applications. The wide range of sizes addresses requirements for multiple fluid transfer uses. APST is extremely flexible, contains no animal-derived ingredients, and offers a temperature range of -100°F to 400°F (-73°C to 204°C). The tubing meets standards for organizations such as USP, FDA, ISO, 3-A, and European Pharmacopoeia. - October 27, 2010 - NewAge Industries, Inc.
Molecular Connections Launches XTractor Lite Semantically Annotated Knowledgebase of PubMed Abstracts That Enables Best Analysis of PubMed
Researchers worldwide face problems like enormous amount of published information. Molecular connections, an Indian Life Sciences Informatics Company, today launched its knowledgebase XTractor Lite that has more than 13 million categorized relationships derived from text mining PubMed abstracts. - October 24, 2010 - Molecular Connections Pvt. Ltd.
PharmApprove Founder Pete Taft to Present at Pharmaceutical Regulatory Affairs Conference
Pete Taft, Founder and CEO of Princeton-based drug development communications firm PharmApprove, has been asked to present and lead a session at the largest global gathering of the pharmaceutical regulatory profession. The 2010 Regulatory Affairs Professionals Society (RAPS) Annual Conference... - October 23, 2010 - Taft and Partners
IQPC Announces New podcast; How Can Polymorph Patents Increase Cost Efficiency?
Head of Intellectual Property and Strategic Planning at Wockhardt, Mandar Kodgule, discusses his views on developing IP strategies for crystalline forms - October 21, 2010 - IQPC
CIS Publishes Corrective Action/Preventative Action (CAPA) System White Paper
CIS, a pharmaceutical compliance consulting firm, announced the publication of its white paper on compliance-focused approaches to establishing an efficient, effective and sustainable Corrective Action/Preventative Action (CAPA) system for pharmaceutical manufacturers. - October 21, 2010 - Compliance Implementation Services
Do You Believe in Cool Chain Excellence? IQPC's Cool Chain Europe Excellence Awards Return for 2011
Nominations are currently being accepted for the Cool Chain Europe Excellence Awards 2011. This runs in conjunction with Cool Chain Europe 2011 brought to you by Pharma IQ (a division of IQPC). - October 16, 2010 - IQPC
Rottenstein Law Group Cautions Victims About Marketing Web Sites Offering Free Case Evaluations
The Rottenstein Law Group is warning victims of defective consumer products about Web sites that are not what they appear to be. The firm cautions users who search online for legal consultation that many Web sites designed to suggest affiliation with a law firm are simply commercial sites soliciting personal information that can be sold and permission to send the user marketing emails directly. - October 13, 2010 - The Rottenstein Law Group
Creativ-Ceutical to be Centre Stage at ISPOR Europe 2010
Strengthening its positioning as one of the major pan-European consulting companies in pricing, market access and health economics, Creativ-Ceutical will be present in force at ISPOR 2010 from 6-9 November in Prague. - October 13, 2010 - Creativ-Ceutical
Peterson & Associates, P.C. is Committed to Helping Patients of Meridia®
Peterson & Associates, P.C. is committed to representing patients of Meridia® that have been a victim of Meridia®. Meridia® , the obesity drug, has been withdrawn due to a potential increased risk of heart attack or stroke, as requested by the FDA. - October 10, 2010 - Peterson & Associates, P.C.
Senior Formulations Scientist at Metrics Earns CPIP Credential
Joseph E. “Joe” Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP™) credential. Awarded by the ISPE Professional Certification Commission, the CPIP credential is the only... - October 09, 2010 - Metrics, Inc.
MedPro Rx, Inc. Listed Among Best Places to Work by Triangle Business Journal
Local Specialty Infusion Pharmacy Places in Top Three for Small Businesses Category - October 07, 2010 - MedPro Rx, Inc.
Production and Market of Polyvinyl Pyrrolidone in China Now Available at ReportsandReports
With increasing demand from downstream industries and support from Chinese government, PVP production and consumption has been growing rapidly in the past few years, and China has become one of most important PVP producers in the world with larger export volume. - October 07, 2010 - marketsandmarkets
Health Decisions CEO to Address Adaptive Patient Enrollment at Achieving Operational Efficiency in Clinical Trials 2010
Dr. Michael Rosenberg will discuss how continuously adapting enrollment during studies prevents delays and setbacks. - October 03, 2010 - Health Decisions
Pharmaceutical Markets in Latin America Reached $50 Billion in Sales
This report covers eight pharmaceutical markets in Latin America including Venezuela, Chile, Brazil, Mexico, Argentina, Colombia, Cuba, and Peru. - October 01, 2010 - MarketResearch.com
New Avandia® Restrictions in the US | Peterson & Assoc., P.C. is Committed to Inform Patients at New Website
Peterson & Assoc., P.C. is providing the latest information for Victims about New Avandia® Restrictions at New Website, www.avandiaheartdamage.com - September 27, 2010 - Peterson & Associates, P.C.
New Companion Diagnostics Require Pharma Strategy Changes, Scientia Advisors Say
For pharma companies with blockbusters already on the market, the new diagnostic tools of personalized medicine, also known as “theranostics,” can lead to a sales decline—a possibility that should “keep drug executives up at night” developing new strategies to maintain their profit margins. - September 25, 2010 - HarrisComGroup/Scientia Advisors
PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India
PharmaZell GmbH, a European Contract Manufacturing Organization for active pharmaceutical ingredients and advanced intermediates, has once again expanded its manufacturing capabilities in India. In 2010, PharmaZell completed construction of a cGMP Kilo-lab at its R&D center in Vizag, India. - September 21, 2010 - PharmaZell
Synowledge to Participate in Pacific Drug Safety Summit
Synowledge LLC announced today that Dr. Jacinta Aniagolu Johnson, Director, Pharmacovigilance and Risk Management, will be representing Synowledge at Pacific Drug Safety Summit at San Francisco Airport Marriott, Burlingame, California, USA on 23rd-24th September 2010. - September 18, 2010 - Synowledge
Synowledge Continues Global Expansion with New Offices in UK and USA
Synowledge LLC, the market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations announced its inauguration of two new offices in Brentford, UK and Columbus OH, USA as part of its ongoing global growth strategy. These two new offices will act... - September 16, 2010 - Synowledge
Synowledge Announces 15 New Customer Wins Worldwide
Synowledge LLC, a market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations of all sizes announced its largest customer win growth to-date. Synowledge signs 15 new customers in 2010 (including a fortune 100 company and a top 20 pharma... - September 10, 2010 - Synowledge
Despite Economic Turmoil, CIS Named to Inc. 5000 List of Fastest-Growing Private Companies in America
Compliance Implementation Services (CIS) announced today that it has been named to Inc. Magazine’s fourth annual Top 5000 list of fastest-growing privately held companies in the United States. - September 09, 2010 - Compliance Implementation Services
GenScript Launches CloneReadyTM Gene Collections
GenScript’s CloneReadyTM Gene Collections provide convenient and cost-effective solutions to researchers’ gene related practices. - September 09, 2010 - GenScript USA Inc.
Newly Developed Cancer Treatments to Generate $25 Billion by 2015 According to Report Posted on MarketReseach.com
This report concentrates on the pharmaceutical and biopharmaceutical market, including biotechnology drug development, orphan drugs, fast track drug status, other accelerated methods for drug approval, pharmaceutical regulatory exclusivity, pediatric expansions, and biosimilars. - September 03, 2010 - MarketResearch.com
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
P.A.N.D.O.R.A. Urges Swift Action by U.S. Health Agencies to Improve Quality of Life for CFS Patients
Patients with chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) in other countries, have endured too many years of misinformation, neglect, and mistreatment. “With a retrovirus infection now demonstrated to be present in the majority of CFS patients, now is the time... - August 25, 2010 - PANDORA Org